AMLX
Price
$14.31
Change
-$0.51 (-3.44%)
Updated
Oct 23 closing price
Capitalization
1.58B
13 days until earnings call
Intraday Buy/Sell Signals
LRMR
Price
$4.20
Change
+$0.25 (+6.33%)
Updated
Oct 24, 12:41 PM (EDT)
Capitalization
336.37M
25 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

AMLX vs LRMR

Header iconAMLX vs LRMR Comparison
Open Charts AMLX vs LRMRBanner chart's image
Amylyx Pharmaceuticals
Price$14.31
Change-$0.51 (-3.44%)
Volume$2.09M
Capitalization1.58B
Larimar Therapeutics
Price$4.20
Change+$0.25 (+6.33%)
Volume$209
Capitalization336.37M
AMLX vs LRMR Comparison Chart in %
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. LRMR commentary
Oct 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a StrongBuy and LRMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 24, 2025
Stock price -- (AMLX: $14.31 vs. LRMR: $3.95)
Brand notoriety: AMLX and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 107% vs. LRMR: 61%
Market capitalization -- AMLX: $1.58B vs. LRMR: $336.37M
AMLX [@Biotechnology] is valued at $1.58B. LRMR’s [@Biotechnology] market capitalization is $336.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, both AMLX and LRMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 2 TA indicator(s) are bullish while LRMR’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 2 bullish, 6 bearish.
  • LRMR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а -5.67% price change this week, while LRMR (@Biotechnology) price change was -7.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +11.17%, and the average quarterly price growth was +62.10%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

LRMR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.58B) has a higher market cap than LRMR($336M). AMLX YTD gains are higher at: 278.571 vs. LRMR (2.067). LRMR has higher annual earnings (EBITDA): -108.21M vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. LRMR (139M). LRMR has less debt than AMLX: LRMR (4.61M) vs AMLX (5.96M). LRMR has higher revenues than AMLX: LRMR (0) vs AMLX (-249K).
AMLXLRMRAMLX / LRMR
Capitalization1.58B336M471%
EBITDA-196.3M-108.21M181%
Gain YTD278.5712.06713,476%
P/E Ratio2.69N/A-
Revenue-249K0-
Total Cash181M139M130%
Total Debt5.96M4.61M129%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXLRMR
RSI
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMCAX44.95N/A
N/A
Fidelity Advisor Stock Selec Mid Cp M
JAGRX64.13N/A
N/A
Janus Henderson VIT Research Instl
ADKSX34.74N/A
N/A
Adirondack Small Cap
RTLAX93.42N/A
N/A
Russell Inv Tax-Managed US Large Cap A
ICEVX47.50-0.13
-0.27%
NYLI Epoch International Choice Class A

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-3.44%
XOMAO - AMLX
68%
Closely correlated
+0.35%
XOMAP - AMLX
51%
Loosely correlated
-0.13%
OCUL - AMLX
47%
Loosely correlated
+0.88%
RGNX - AMLX
45%
Loosely correlated
+3.20%
JAZZ - AMLX
43%
Loosely correlated
-0.25%
More